Get the Stockscreener App
13.56
2.19%
0.29
After Hours:
13.59
0.03
+0.22%
Si Bone Inc stock is traded at $13.56, with a volume of 143.84K.
It is up +2.19% in the last 24 hours and up +3.43% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$13.27
Open:
$13.36
24h Volume:
143.84K
Relative Volume:
0.41
Market Cap:
$568.68M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-10.04
EPS:
-1.35
Net Cash Flow:
$-25.98M
1W Performance:
+7.96%
1M Performance:
+3.43%
6M Performance:
+0.22%
1Y Performance:
-26.30%
1-Day Range:
$13.31
$13.79
1-Week Range:
$12.55
$13.79
52-Week Range:
$11.70
$21.70
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
13.56 | 568.68M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SI-BONE Inc (SIBN) Shares Up 2.75% on Nov 29 - GuruFocus.com
SI-BONE, Inc. (NASDAQ:SIBN) Sees Large Decline in Short Interest - MarketBeat
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? - MSN
SI-BONE Inc (SIBN) Trading 3.4% Higher on Nov 27 - GuruFocus.com
Millrace Asset Group Inc. Buys Shares of 75,542 SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
SI-BONE's SWOT analysis: medical device maker's stock poised for growth - Investing.com
SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Champlain Investment Partners LLC - MarketBeat
SI-BONE (NASDAQ:SIBN) Earns Buy Rating from Needham & Company LLC - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Receives $23.00 Average Target Price from Brokerages - MarketBeat
Si Bone stock hits 52-week low at $11.75 amid market challenges - Investing.com Australia
SI-BONE (NASDAQ:SIBN) Hits New 52-Week Low After Insider Selling - Defense World
Si Bone stock hits 52-week low at $11.75 amid market challenges By Investing.com - Investing.com South Africa
Si-Bone CEO Laura Francis sells $126,353 in common stock By Investing.com - Investing.com Australia
Si-Bone CEO Laura Francis sells $126,353 in common stock - Investing.com India
Needham sees buying opportunity for SI-BONE stock amid recent weakness By Investing.com - Investing.com South Africa
Si-Bone CFO Anshul Maheshwari sells $30,936 in stock By Investing.com - Investing.com Canada
Si-Bone's president sells shares valued at $74,802 By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey W. Dunn sells shares worth $20,001 By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey W. Dunn sells shares worth $20,001 - Investing.com
Si-Bone CFO Anshul Maheshwari sells $30,936 in stock - Investing.com
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 - The Manila Times
SI-BONE to Present at Piper Sandler Healthcare Conference in December | SIBN Stock News - StockTitan
Needham & Company LLC Reiterates "Buy" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
Needham sees buying opportunity for SI-BONE stock amid recent weakness - Investing.com
The Analyst Verdict: SI-BONE In The Eyes Of 4 Experts - Benzinga
Cantor Fitzgerald Boosts Earnings Estimates for SI-BONE - Defense World
Cantor Fitzgerald Increases Earnings Estimates for SI-BONE - MarketBeat
SI-BONE (NASDAQ:SIBN) Price Target Raised to $18.00 at Truist Financial - Defense World
SI-BONE (NASDAQ:SIBN) Trading Up 3.9%Here's What Happened - MarketBeat
Impax Asset Management Group plc Acquires 221,604 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
Analysis of First Light Asset Management's Recent Reduction in S - GuruFocus.com
SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
How to Take Advantage of moves in (SIBN) - Stock Traders Daily
SI-BONE Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Santa Clara company's hip fracture tech gains momentum - The Business Journals
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance - OrthoSpineNews
Needham & Company LLC Reaffirms Buy Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Q3 2024 Earnings Call Transcript - Insider Monkey
SI-BONE posts USD 40.3M revenue, a 19% increase in Q3 2024 - Medical Buyer
Si-Bone: Q3 Earnings Snapshot - CT Insider
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Reve - GuruFocus.com
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability - Yahoo Finance
SI-BONE Reports Strong Q3 Growth and Optimistic Outlook - TipRanks
Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
SI-BONE Inc Reports Q3 2024 Revenue of $40.3M and EPS of -$0.16, Slightly Missing Estimates - GuruFocus.com
Si-Bone earnings beat by $0.08, revenue fell short of estimates - Investing.com UK
SI-BONE Q3 Revenue Surges 19% to $40.3M, Slashes EBITDA Loss by 94% | SIBN Stock News - StockTitan
SI-BONE Inc (SIBN) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
SI-BONE (SIBN) Set to Announce Quarterly Earnings on Tuesday - Defense World
Si-Bone director Jeffrey Dunn sells $4,620 in common stock - Investing.com
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):